These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 20185821)

  • 1. A pathway involving farnesoid X receptor and small heterodimer partner positively regulates hepatic sirtuin 1 levels via microRNA-34a inhibition.
    Lee J; Padhye A; Sharma A; Song G; Miao J; Mo YY; Wang L; Kemper JK
    J Biol Chem; 2010 Apr; 285(17):12604-11. PubMed ID: 20185821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated microRNA-34a in obesity reduces NAD+ levels and SIRT1 activity by directly targeting NAMPT.
    Choi SE; Fu T; Seok S; Kim DH; Yu E; Lee KW; Kang Y; Li X; Kemper B; Kemper JK
    Aging Cell; 2013 Dec; 12(6):1062-72. PubMed ID: 23834033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-144 regulates hepatic ATP binding cassette transporter A1 and plasma high-density lipoprotein after activation of the nuclear receptor farnesoid X receptor.
    de Aguiar Vallim TQ; Tarling EJ; Kim T; Civelek M; Baldán Á; Esau C; Edwards PA
    Circ Res; 2013 Jun; 112(12):1602-12. PubMed ID: 23519696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective FXR-SHP Regulation in Obesity Aberrantly Increases
    Seok S; Sun H; Kim YC; Kemper B; Kemper JK
    Diabetes; 2021 Mar; 70(3):733-744. PubMed ID: 33328206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbon monoxide protects against hepatic ischemia/reperfusion injury by modulating the miR-34a/SIRT1 pathway.
    Kim HJ; Joe Y; Yu JK; Chen Y; Jeong SO; Mani N; Cho GJ; Pae HO; Ryter SW; Chung HT
    Biochim Biophys Acta; 2015 Jul; 1852(7):1550-9. PubMed ID: 25916635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P53/miR-34a/SIRT1 positive feedback loop regulates the termination of liver regeneration.
    Gong J; Cong M; Wu H; Wang M; Bai H; Wang J; Que K; Zheng K; Zhang W; Yang X; Gong J; Shi H; Miao M; Yuan F
    Aging (Albany NY); 2023 Mar; 15(6):1859-1877. PubMed ID: 36988541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease.
    Castro RE; Ferreira DM; Afonso MB; Borralho PM; Machado MV; Cortez-Pinto H; Rodrigues CM
    J Hepatol; 2013 Jan; 58(1):119-25. PubMed ID: 22902550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-Jun N-terminal kinase 1/c-Jun activation of the p53/microRNA 34a/sirtuin 1 pathway contributes to apoptosis induced by deoxycholic acid in rat liver.
    Ferreira DM; Afonso MB; Rodrigues PM; Simão AL; Pereira DM; Borralho PM; Rodrigues CM; Castro RE
    Mol Cell Biol; 2014 Mar; 34(6):1100-20. PubMed ID: 24421392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PU.1-deficient mice are resistant to thioacetamide-induced hepatic fibrosis: PU.1 finely regulates Sirt1 expression via transcriptional promotion of
    Liu Q; Zhang Y; Yang S; Wu Y; Wang J; Yu W; Liu Y
    Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29162670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cadmium chloride induces non-alcoholic fatty liver disease in rats by stimulating miR-34a/SIRT1/FXR/p53 axis.
    Alshehri AS; El-Kott AF; El-Kenawy AE; Khalifa HS; AlRamlawy AM
    Sci Total Environ; 2021 Aug; 784():147182. PubMed ID: 34088068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-122 Inhibits Lipid Droplet Formation and Hepatic Triglyceride Accumulation via Yin Yang 1.
    Wu GY; Rui C; Chen JQ; Sho E; Zhan SS; Yuan XW; Ding YT
    Cell Physiol Biochem; 2017; 44(4):1651-1664. PubMed ID: 29216638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ablation of carotenoid cleavage enzymes (BCO1 and BCO2) induced hepatic steatosis by altering the farnesoid X receptor/miR-34a/sirtuin 1 pathway.
    Lim JY; Liu C; Hu KQ; Smith DE; Wang XD
    Arch Biochem Biophys; 2018 Sep; 654():1-9. PubMed ID: 30006135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of p53/miR-34a/SIRT1 axis ameliorates podocyte injury in diabetic nephropathy.
    Liang Y; Liu H; Zhu J; Song N; Lu Z; Fang Y; Teng J; Dai Y; Ding X
    Biochem Biophys Res Commun; 2021 Jun; 559():48-55. PubMed ID: 33932899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-34a: a novel tumor suppressor in p53-mutant glioma cell line U251.
    Luan S; Sun L; Huang F
    Arch Med Res; 2010 Feb; 41(2):67-74. PubMed ID: 20470934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the miR-34a/SIRT1/p53 Signaling Pathway Contributes to the Progress of Liver Fibrosis via Inducing Apoptosis in Hepatocytes but Not in HSCs.
    Tian XF; Ji FJ; Zang HL; Cao H
    PLoS One; 2016; 11(7):e0158657. PubMed ID: 27387128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bile acid receptor agonist GW4064 regulates PPARγ coactivator-1α expression through estrogen receptor-related receptor α.
    Dwivedi SK; Singh N; Kumari R; Mishra JS; Tripathi S; Banerjee P; Shah P; Kukshal V; Tyagi AM; Gaikwad AN; Chaturvedi RK; Mishra DP; Trivedi AK; Sanyal S; Chattopadhyay N; Ramachandran R; Siddiqi MI; Bandyopadhyay A; Arora A; Lundåsen T; Anakk SP; Moore DD; Sanyal S
    Mol Endocrinol; 2011 Jun; 25(6):922-32. PubMed ID: 21493670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinoid X receptor α in human liver is regulated by miR-34a.
    Oda Y; Nakajima M; Tsuneyama K; Takamiya M; Aoki Y; Fukami T; Yokoi T
    Biochem Pharmacol; 2014 Jul; 90(2):179-87. PubMed ID: 24832862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlling SIRT1 expression by microRNAs in health and metabolic disease.
    Lee J; Kemper JK
    Aging (Albany NY); 2010 Aug; 2(8):527-34. PubMed ID: 20689156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oligochitosan-based nanovesicles for nonalcoholic fatty liver disease treatment via the FXR/miR-34a/SIRT1 regulatory loop.
    Kong M; Peng Y; Qiu L
    Acta Biomater; 2023 Jul; 164():435-446. PubMed ID: 37040811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic deletion of SIRT1 decreases hepatocyte nuclear factor 1α/farnesoid X receptor signaling and induces formation of cholesterol gallstones in mice.
    Purushotham A; Xu Q; Lu J; Foley JF; Yan X; Kim DH; Kemper JK; Li X
    Mol Cell Biol; 2012 Apr; 32(7):1226-36. PubMed ID: 22290433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.